15433-78-0 Usage
Uses
Used in Pharmaceutical Industry:
(5-(piperidin-1-ylMethyl)furan-2-yl)Methanol is used as a chemical intermediate for the development of various pharmaceutical compounds. Its unique structure, which includes a basic piperidine group and an aromatic furan ring, makes it a promising candidate for the synthesis of new drugs with potential therapeutic applications.
Used in Organic Synthesis:
(5-(piperidin-1-ylMethyl)furan-2-yl)Methanol is used as a building block in the synthesis of other organic compounds. Its reactivity and structural features can be exploited to create a wide range of molecules with diverse properties and potential applications in various fields, including materials science, agrochemicals, and specialty chemicals.
Used in Research and Development:
(5-(piperidin-1-ylMethyl)furan-2-yl)Methanol is used as a research compound for studying its properties, reactivity, and potential applications. Scientists and researchers in the field of organic chemistry and pharmaceuticals can utilize (5-(piperidin-1-ylMethyl)furan-2-yl)Methanol to explore new reaction pathways, develop novel synthetic methods, and investigate its interactions with biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 15433-78-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,4,3 and 3 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 15433-78:
(7*1)+(6*5)+(5*4)+(4*3)+(3*3)+(2*7)+(1*8)=100
100 % 10 = 0
So 15433-78-0 is a valid CAS Registry Number.
15433-78-0Relevant academic research and scientific papers
Feriani, Aldo,Gaviraghi, Giovanni,Toson, Giancarlo,Mor, Marco,Barbieri, Annalisa,et al.
, p. 4278 - 4287 (1994)
In the first part of this study, devoted to the discovery of selective antimuscarinic agents, (+/-)-N--2-furfuryl>dimethylamine (5a) proved to be at least 20 times more potent in the rat ileum and bladder than in
Sulfur-containing compound based on glutaryl imide skeleton and application of compound
-
Paragraph 0167; 0747-0748, (2020/09/12)
The present disclosure relates to compound shown in a formula (I) or salts, solvates, isotope-enriched analogs, tautomers, polymorphs, stereoisomers, or mixtures of stereoisomers of the compound, andthe application thereof in the treatment of tumours. The present disclosure also provides tumor treatment application of the compound showed in a formula (I') or pharmaceutically acceptable salts, solvates, isotope-enriched analogs, tautomers, polymorphic substances, stereoisomers, or mixtures of stereoisomers of the compound.
